跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40 条关于
“SLC6A1”
全部
40
临床试验
24
药物
4
机构
0
资讯
12
去年
4-Phenylbutyrate Shows Promise in Treating Genetic Epilepsy in Children
11天前
Nature Reviews Drug Discovery Review Positions SLC Transporters as Untapped Frontier in CNS Drug Development
去年
Maze Therapeutics Initiates Phase 1 Trial of MZE782 for Chronic Kidney Disease
去年
Maze Therapeutics' MZE782 Shows 42-Fold Increase in Phenylalanine Excretion in Phase 1 Trial for PKU and CKD
上个月
Maze Therapeutics Appoints Paula Johnson and Sophie Kornowski to Board of Directors
去年
Phenylketonuria Pipeline Shows Robust Growth with 25+ Therapies in Development
5个月前
PRMT5 Inhibition Sensitizes B-Cell Lymphoma to Ferroptosis via ATF5-SLC7A11 Axis
3个月前
SLC6A20-Targeting ASO Restores NMDA Receptor Function in Autism Models, Offering New Therapeutic Strategy
8个月前
Enodia Therapeutics Secures €20.7M Seed Funding to Advance Novel Protein Degradation Platform Targeting SEC61 Translocon
上个月
Protein Partnership Specificity Explains Regional Brain Vulnerability in SCA1 and Beyond
第 1 页,共 2 页
上一页
下一页